Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Bariatric Surgery: Reduced CVD Risk via PREVENT Equations
Author(s): Danxia Yu Added: 9 months ago
Outcomes from a new CV disease risk assessment tool show significant improvements in CV, kidney and metabolic health after bariatric surgery. The study also found a reduction in estimated 10 year risk of developing total CV disease and a reduction in the risk of developing heart failure one year after bariatric surgery.In this short interview, Dr Danxia Yu (Vanderbilt University Medical Center,… View more

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
TCT Middle East 25: Minimally Invasive Surgery
Author(s): Rania Hammami , Uthman Aluthman Added: 8 months ago
TCT Middle East 2025 — We are joined by Prof Rania Hammami and Dr Uthman Aluthman as they discuss the key takeaways for minimally invasive surgery from the conference.The specialists provide insights on evolving definitions and expanding applications of minimally invasive cardiac surgical techniques. They address practical considerations regarding patient selection, recovery trajectories, and… View more

Intervention
TCT 24: The MATTERHORN Trial
Author(s): Stephan Baldus Added: 1 year ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,… View more

Heart Failure

Intervention
ESC 24: The MATTERHORN Trial
Author(s): Volker Rudolph , Stephan Baldus Added: 1 year ago
ESC Congress 2024 — TEER non-inferior to mitral valve surgery with regard to death, HF rehospitalisation, stroke, reintervention of LVAD at one year.Dr Volker Rudolph (Heart and Diabetes Center NRW, DE) and Prof Stephan Baldus (University Hospital of Köln, DE) joins us in London to discuss the MATTERHORN trial (NCT02371512; University Hospital of Köln).This multicenter, randomized controlled… View more

Intervention
AHA 24: The SELECT Trial
Author(s): Subodh Verma Added: 1 year ago
AHA Conference 2024 - Outcomes of SELECT show that semaglutide treatment in obese or overweight patients with prior history of coronary artery bypass graft (CABG) surgery reduces the risk of cardiovascular events.Dr Subodh Verma (University of Toronto, Toronto, CA) joins us onsite at AHA Conference to discuss the findings from SELECT (NCT03574597).SELECT is a randomized, double-blind, placebo… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
The European Association for Cardio-Thoracic Surgery was founded in 1986 as a European organisation devoted to the practice of cardio-thoracic surgery. Membership has now spread all over the world with 4000 active members including surgeons, perfusionists and allied health professionals.The mission of the Association is to advance education in the field of cardiac, thoracic and vascular… View more
TCT 25: Seven-Year Follow-up of the PARTNER 3 Trial
Author(s): Michael J Mack Added: 2 months ago
TCT 2025 - Long-term follow-up of the PARTNER 3 trial showed no safety concerns for transcatheter aortic-valve replacement (TAVR) compared to surgical treatment of aortic stenosis (AS).Dr Michael Mack (Baylor Scott & White Heart Hospital, Plano, US) joins us to share the clinical and echocardiographic outcomes from the seven-year follow-up of the PARTNER 3 low-risk randomised trial (NCT02675114)… View more

Imaging & Diagnostics

Intervention
Job title: Professor of Surgery and Head of the Department of Cardiac Surgery